Kim G. Smolderen
机构:Yale University · ORCID:0000-0001-6104-6254
发表论文 410 篇 · 总被引 5014 次 · h-index 37
代表论文
- Lower risk of cardiovascular events in patients initiated on semaglutide 2.4 mg in the real‐world: Results from the SCORE study (Semaglutide Effects on Cardiovascular Outcomes in People with Overweight or Obesity in the Real World) (2025 · Diabetes Obesity and Metabolism · 被引 12)
- Periprocedural outcomes of embolic protection device use in carotid artery stenting (2025 · Journal of Vascular Surgery · 被引 3)
- Exposure-based Interventions for Chronic Pain and Bodily Symptoms: A Special Interest Meeting Report (2026 · Behaviour Research and Therapy · 被引 2)
- Lower Risk of Cardiovascular Events in Patients With Clinical Atherosclerotic Cardiovascular Disease Who Initiated Semaglutide 2.4 mg in the Real‐World: Results From the SCORE—Clinical ASCVD Study (2026 · Diabetes Obesity and Metabolism · 被引 1)
- Association between semaglutide 2.4 mg and risk of cardiovascular events in people with overweight or obesity without atherosclerotic cardiovascular disease in the real-world: The SCORE – primary prevention study (2026 · American Journal of Preventive Cardiology · 被引 1)
- Applying a Random Forest Approach in Predicting Health Status in Patients with Carotid Artery Stenosis 30 Days Post Stenting (2025 · Stroke Vascular and Interventional Neurology · 被引 1)